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Embryology, Medical University of Silesia, Katowice, PolandObjectives. One of the important factors responsible for vessel wall remodelling is programmed cell death. In the paper the
role of smooth muscle cell (SMC) apoptosis in primary varicose veins (PVV) is investigated.
Material and methods. Vein specimens were obtained from 40 patients with PVV. In each case proximal and distal (upper
crural) great saphenous veins (GSV) were harvested. Morphometric computer assessed quantitative evaluation of SMCs,
collagen and elastin content was carried out. Apoptotic cells were detected by TUNEL assay. The levels of p53, BAX, BCLl-
2 and p21 mRNA expression were assessed by real time RT-QPCR and the presence of respective proteins in the vessel wall
was confirmed by immunohistochemistry.
Results. In the proximal GSV segments a significant increase of p53, p21 and BCL-2 mRNA levels was found in PVV
patients. In the distal segments BAX and BCL-2 expression levels were higher. Taking into account the patient age, elevated
p53 mRNA expression level was noticed in the distal incompetent GSVs of young PVV patients. In this group a statistically
significant increase in the apoptotic index (APIx) within the vein media was found which correlated positively with p53
mRNA expression level. There was no increase of the apoptotic activity in elderly patients that led to the structural changes
increase. In proximal GSV segments, despite SMC amount reduction or presence of structural changes in perivalvular wall
region, no increase of the APIx with was noticed.
Conclusions. P53—related apoptosis is one of the regulatory mechanisms of vein wall homeostasis maintenance. During
varicose vein development its activation is related to the early stages of the disease. In the further course, the down-regulation
of the SMC apoptosis within the vein media leads to the structural changes increase. The reduction of the SMC population
corresponding to an increase of p21 expression in proximal saphenous vein segments suggests that the cell cycle
disturbances may lead to the ‘weakness’ of the proximal GSV wall. Valve injury is not the only factor leading to the varicose
veins occurrence.Keywords: Primary varicose veins; Apoptosis; Saphenous vein; Smooth muscle cells.Introduction
Despite many theories, the pathogenesis of lower
extremity varicose veins is still under discussion.1–3
The occurrence of this disease, even in the very young,
confirms the role of the proper development and
correct regulation of tissue and organ maturation.
Inherited factors are important in the development of
superficial venous reflux.3,4 One of the factors influen-
cing vascular wall development and remodelling is
programmed cell death, which regulates tissue mass
and its architecture.5–7 One of the most important
factors influencing cell viability at the molecular leveling author. Tomasz Urbanek MD, PhD, Department of
Vascular Surgery Medical University of Silesia,
Ziołowa 45/47, 40-635 Katowice, Poland.
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0600 + 12 $35.00/0 q 2004 Elsevier Ltd. All rights reseris the balance between proapoptotic and antiapoptotic
signals mediated by a number of gene families
promoting cell survival or apoptosis.5,7,8 A number
of studies have demonstrated programmed cell death
in vessels that remodel postnatally.7–9 This process
also appears to be a feature of vessel wall remodelling
occurring in atherosclerosis, inflammatory vessel
diseases or aneurysm formation.7,8,10 Apoptotic
death may concern vascular smooth muscle cells
(SMCs) that are of great importance for proper vein
architecture and its tone. Although apoptosis is also
observed in other cell populations such as endothelial
cells and the cells of inflammatory response, there are
still very few data about the role of programmed cell
death in varicose vein wall injury.11–13 In this study, the
role of SMC apoptosis and its regulatory mechanism in
patients with varicose veins were investigated. The
expression of p53, BAX, BCL-2 and p21 and theirEur J Vasc Endovasc Surg 28, 600–611 (2004)
doi:10.1016/j.ejvs.2004.09.008, available online at http://www.sciencedirect.com onved.
Apoptosis in Varicose Veins 601influence on vein wall homeostasis maintenance were
evaluated.Material and MethodsMaterial
The vein specimens were obtained from 40 patients
(20F/20M) with primary varicose veins (stage C2,EP,-
AS3,PR according to the CEAP classification) under-
going sapheno-femoral ligation and great saphenous
vein (GSV) stripping. The local Ethics Committee
considered and approved the study protocol and
informed patient consent was obtained. Duplex ultra-
sonography was performed preoperatively, confirm-
ing the presence of incompetent, dilated proximal GSV
near the femoral junction with its undilated (!6 mm)
femoral segment and varicose veins of the incompe-
tent GSV in the calf. All the patients had a competent
deep vein system without a history of thrombotic
episodes. Patients with any concomitant disease were
excluded from the study. In 60% of the patients a
family history of varicose veins in parents, brothers or
sisters was reported. The patients were divided into
groups according to age (!50 years, O50 years) and
sex (F/M). In total, there were 20 younger patients
(median 34.8 years; 19–47, 10F/10M) and 20 patients
older than 50 (median 60.2 years; 52–74, 10F/10M).
The mean disease duration was 14 years (from 3 to 20
in young patients—median 8.5 years, and from 4 to 40
in the elderly group—median 16.7 years). All the
patients were operated on at the Department of
General and Vascular Surgery, Medical University of
Silesia. From each patient two specimens were
harvested—proximal GSV (dilated vein below the
incompetent sapheno-femoral junction—if possible
with the valve) and distal (upper calf) GSV (the first
surgically removed dilated distal GSV segment).
Among the resected veins, the presence of incompe-
tent valves within the specimens was found in 17
proximal and 20 distal GSV segments. Two separate
control groups were studied: Group I—10 patients
undergoing venous femoro–popliteal bypass for per-
ipheral arterial occlusive disease (median 65.5 years;
50–76). Group II—young, non-fibrotic specimens (9
GSVs) were harvested from multiorgan donors
(median age 35.7 years; 19–45). The specimens were
fixed in 10% neutral buffered formalin for 18 h before
paraffin embedding. For the gene expression determi-
nation, material (from the same segments) was frozen
at K80 8C.Pathological examination
Verhoeff–Van Gieson staining was employed followed
by computer assessed quantitative morphometry of
the elastin, collagen and SMCs within the vein wall.
Digital image acquisition involved a Nikon Eclipse
E600 microscope connected to a SONY Exwave HAD
SSC-DC58AP video camera and PCI frame-grabber
(Brook Tree 576) 768!576 pixels working at 24 bit RGB
colour resolution. For image analysis the Image Pro
Plus 4.5 (Media Cybernetics) program was used.
Thirty fields were photographed electronically from
each slice (5 slices from each vein specimen)—10 for
each wall layer. All images were taken at 100!
magnification. Colour segmentation of the images
was performed according to the HSI model (H—Hue,
S—Saturation, I—Intensity). The colour histogram
ranges were as follows: myocytes H (0–255)—S (4–
40)—I (0–250), collagen H (210–240)—S (20–200)—I
(100–240), elastin H (0–255)—S (0–255)—I (0–140). The
percentage of the fields containing myocytes, collagen
and elastin was calculated. The area of the intima,
media and whole cross section areas of the specimens
were also measured.Detection of apoptosis
The presence of apoptotic cells was detected immu-
nohistochemically based on the labelling of DNA
strand breaks by TUNEL assay (terminal deoxynu-
cleotide—mediated dUTP nick end labelling). The
investigation was performed using an in situ cell death
detection kit (ApopTag Plus peroxidase in situ Apop-
tosis detection Kit; Serologicals Corporation) accord-
ing to the method described in the kit manual. The
results were assessed by two independent investi-
gators—the whole number of apoptotic cells was
counted for each section in the respective layers—
intima, media, adventitia (the number of endothelial
apoptotic cells was not taken into consideration in the
statistical analysis). An apoptotic index was calculated
according to the formula: [number of apoptotic
cells/total number of nuclei]!100. For assessment of
the total nuclei number the slices were stained with
Grenacher’s carmine and a computer analysis (Image
Pro Plus 4.5) was done—an automatic detection of the
nuclei was based on predefined colour assessment and
morphological evaluation.Gene expression assessment (real time RT-QPCR)
Total RNA was isolated from 100 mg of homogenized
tissue with Trizol reagent (Invitrogen) as previouslyEur J Vasc Endovasc Surg Vol 28, December 2004
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by means of UV spectrophotometry (Beckman-VIS)
and the gene expression was assessed by real time
quantitative RT-PCR according to the TaqMan meth-
odology by the ABI PRISM 7700 Sequence Detection
System (Applied Biosystem). To normalize the amount
of the total RNA, endogenous reference (GAPDH)
gene was used. Assessment of the results use the
comparative CT method (according to the Sequence
Detector User Bulletin#2, Applied Biosystem). PCR
reaction was simultaneously performed for control
and investigated genes (p53, BAX, BCL-2, p21).
Commercially available kits containing probes and
primers for specific mRNA sequence were used
(Applied Biosystem). The reaction was performed
using TaqMan PCR kit (Applied Biosystem). The RT
reaction was performed at 48 8C for 30 min. PCR
thermal conditions were as follows: 10 min 95 8C/15 s
95 8C and 1 min 60 8C for a total of 40 cycles/10 min
72 8C.Immunostaining
To confirm the presence of the gene products in the
tissue sections an immunostaining for p53, Bax, BCL-2
and p21 proteins was performed. The type of
apoptotic cells was assessed by means of a-actin
(SMCs), CD 3 (T lymphocyte), CD 68 (macrophages)
and CD 20 (B lymphocyte) stainings. Anti-CD3, CD 68
and CD 20 antibodies were also used to assess the
presence of inflammatory cell infiltration within the
vein wall. The following antibodies were used:
monoclonal mouse anti-human: BCL-2, p53, CD 68,
CD 3, a-actin (DAKO) with Universal DAKO Labelled
Streptavidin-Biotin 2 System (Horseradish Peroxidase)/
monoclonal mouse anti-human CD 20, p21 (DAKO)
with DAKO LSAB kit/polyclonal rabbit, anti-human
Bax (DAKO) with a catalysed signal amplification
(CSA) system. The staining was assessed in 10
randomly selected fields for each specimen. The
results of the p53, p21 and BCL-2 staining were
expressed graphically as a number of positive cells
per 1000 cells. The results of anti-BAX staining, due to
the dispersed character of immunostaining were
assessed fromK to CCC.Statistical analysis
The differences between the groups were investigated
by means of ANOVA and non-parametric Kruskal–
Wallis, U Mann–Whitney and Wilcoxon tests; value of
p!0.05 was considered statistically significant. For the
graphic presentation of the statistical analysis results,Eur J Vasc Endovasc Surg Vol 28, December 2004the STATISTCA 6 (StatSoft) was used. Correlation
analysis was performed by the Pearson correlation
test. To assess an inter-observer agreement in the
apoptotic index evaluation k values were calculated
(MedCalc). Altman recommendations for k values as
expressions of strength of agreement were used.15ResultsVein wall morphometric analysis
Intima
The thickness of the intima ranged from 4.7 to 36 mm in
control veins versus 8.8–85 mm in the proximal and 5–
133 mm in the distal GSV in varicose vein patients.
According to the computer assessed morphometric
analysis the total cross sectional area of the intima of
the incompetent GSV was greater (p!0.05) in both:
proximal and distal segments (data not shown). In the
patients with varicose veins an irregular accumulation
of collagen fibres within the intimal layer was
observed with disruption of muscle bundles and
internal elastic lamina of the incompetent GSVs.
In proximal GSV segments taken from young
subjects an insignificant increase in the muscle
component with constant collagen compound was
found (Fig. 1a and b). In the older patients the
proximal segments a trend towards increased
amounts of SMC was observed (p!0.1) (Fig. 1a).
Distally, compared to control veins, in young
varicose vein patients, slightly reduced elastin was
found (p!0.1) (Fig. 1c) with comparable collagen and
myocyte amounts per area field were observed.
Because of an increase of the intima cross-section
area due to the thickening of this vein layer, the total
collagen and SMC amounts increased. In the elderly
population with varicose veins, a slight myocyte
accumulation (p!0.1) (Fig. 1a) within the distal GSV
was reported and thickening of this layer was
observed as well. Due to the enhanced intimal fibrosis
in the elderly control subjects (patients who under-
went femoro–popliteal bypass) the relative collagen
amount in the distal segments of the control group was
higher than in varicose vein patients (p!0.05) (Fig. 1b)
but the thickness of this layer was significantly smaller.
Comparing distal and proximal segments a higher
muscle amount was present in the intima of the distal
segments (pZ0.05) (Fig. 1a) with similar collagen and
lower elastin content (p!0.004) (Fig. 1b and c).
Media
In the media an increase of fibrous tissue with irregular
Fig. 1. (a–c) Morphometric analysis—% of the SMC, collagen and elastin amounts in the intima of the control [,] and
incompetent [:] GSVs in the group of younger and older patients (!50 orO50 year old). The level of statistical significance:
*p!0.05, **p!0.1.
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regular pattern of the muscle bundles was observed.
The accumulation of the extracellular matrix was more
evident in the distal segments than in proximal ones.
In the proximal segments a decrease in myocyte
area (p!0.05) (Fig. 2a) with comparable collagen
content and elastin increase p!0.05) (Fig. 2c) was
noticed in the young patient group only.
In the distal dilated GSV of the varicose vein
patients the decrease of the SMC content (p!0.05)
(Fig. 2a) and increase of collagen amount (p!0.05)
(Fig. 2b) were observed. Concerning the patients’ age,
distally, the SMC relative amount was bigger in the
older population (p!0.05) (Fig. 2a). However, in these
specimens significant variations of the nucleus density
in the analysed fields of the specimens were observed
with the prevalence of the decrease of the nucleus
number per SMC area.
The cross-sectional area of the vein media in the
proximal and distal segment specimens did not differ
significantly in comparison with the control group.Adventitia
Compared with the control veins in the proximal vein
segments no differences in the myocyte and elastin
amounts were observed with statistically significant
decrease in the collagen amount (p!0.05) in the
varicose vein patients. In the distal segments SMC
reduction (p!0.05) was noticed. Comparing the distal
and proximal segments, no important differences were
found in the global population, however, taking into
consideration patients’ age in the proximal segment of
young patients, lower muscular (p!0.05) and higher
elastin (p!0.05) amounts were noticed.
Further, morphometric assessment focused on the
vein wall components of the vein segments in the
region of the valve attachment did not show any
statistically significant differences in the SMC, elastin
and collagen contents in the intima, media and
adventitia of the respective groups of patients com-
pared with those without valves.
According to the anti-CD 68, anti-CD 3, and anti-CD
20 staining results, no presence of inflammatory cell
infiltrations was found in the perivalvular region and
other vein segments. Single macrophages were stained
within intima and media. In the adventitia beside
small number of CD-68 positive cells, few T lympho-
cytes were found.TUNEL assay
TUNEL positive cells were detected in the intima in
36% of the control and 45% of incompetent GSVEur J Vasc Endovasc Surg Vol 28, December 2004specimens, in the media in 89.4 and 92.5% and in the
adventitia in 73 and 82.5%, respectively. The strength
of intraobserver agreement in the apoptotic cell
number assessment was very good in the vein media
(k value K0.81) and good for intima and adventitia
(k values K0.72 and 0.61 for intima and adventitia,
respectively). In all layers of the control and incompe-
tent veins a very low apoptotic index was noted
(Table 1).
In the whole population, in any of the wall layer,
there were no statistically significant differences in the
apoptotic index between incompetent proximal or
distal vein segments compared with the control group.
Taking into account the patients’ age a statistically
significant increase of the apoptotic index was found
in the media of the distal (upper crural) region in the
young patients with varicose veins (control 0.0069 SD
0.004 vs. varicose veins 0.014 SD 0.005; p!0.05). No
other differences between competent and incompetent
vein specimens were reported in the respective vein
layers.
Comparing proximal and distal GSV specimens a
higher apoptotic index in the adventitia of the distal
incompetent GSVs was noticed (p!0.05).
Double staining revealed that the media TUNEL
positive cells were a-actin positive, whereas in the
adventitia both apoptotic smooth muscle and inflam-
matory cells (mostly macrophages-CD 68 positive and
a few T lymphocytes-CD 20 positive) were present.
There were no changes between the rate of apoptotic
cells in the intima, media or adventitia in the region of
valve attachment and other vein fragments.Gene expression assessment (RT-QPCR)
The levels of p53, BAX, BCL-2 and p21 expression in
the respective groups according to the patients’ age (!
orO50 years) and harvested vein segments (proximal
or distal) are presented in Fig. 3a–d. Comparing
control and incompetent GSVs, in the proximal
segments a statistically significant increase of p53,
p21 and BCL-2 levels (p!0.05) was found in the
varicose vein patients (Fig. 3a–c). The observed
changes were both: sex and age independent.
In the distal GSV segments BCL-2 and BAX mRNA
expression levels were elevated (p!0.05) in the whole
varicose patient group (Fig. 3c and d). Additionally, in
the group of varicose patients younger than 50, also
p53 mRNA expression was higher than in the control
(p!0.05) (Fig. 3a).
In the vein media, a statistically significant corre-
lation was found between the p53 expression and
Fig. 2. (a–c) Morphometric analysis—% of the SMC, collagen and elastin amounts in the media of the control [,] and
incompetent [:] GSVs in the group of younger and older patients (!50 orO50 year old). The level of statistical significance:
*p!0.05, **p!0.1.
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Table 1. Apoptotic index value (mean, SD)
Proximal great saphenous vein Distal great saphenous vein
Control Incompetent GSV Control Incompetent GSV
Intima 0.11 S.D. 0.09 0.07 S.D. 0.06 0.06 S.D. 0.06 0.12 S.D. 0.09
Media 0.017 S.D. 0.01 0.016 S.D. 0.013 0.02 S.D. 0.01 0.017 S.D. 0.01l
Adventitia 0.04 S.D. 0.03 0.03 S.D. 0.02 0.03 S.D. 0.02 0.05 S.D. 0.04
T. Urbanek et al.606apoptotic index, but only in the distal segment of the
young patient group (rZ0.51; p!0.05).
There were no important findings concerning
intima but it should be emphasized that apoptotic
cells in this layer were present only in 36% of the
control and 45% of the incompetent vein specimens,
respectively.
In the adventitia, the correlation between apoptotic
index and BAX expression was documented only in
the control group (rZ0.68; p!0.05).
In all the specimens a higher BAX than BCL-2
mRNA expression was found (BAX to BCL-2 index:
control proximal 4.1, varicose veins proximal 2.2,
control distal 2.2, varicose veins distal 2.3). Taking
into consideration the patient age, this ratio was
significantly higher in the distal segment of the
young patient group (control—1 vs incompetent
GSV—3.2).Immunostaining
P53 staining was present in all the layers of both
control and incompetent veins (mostly in the media
with very low immunoreactivity in the intima and
adventitia). BCL-2 positive cells were present in the
media and adventitia of the control and varicose veins
with minimal staining in intima. The p21 immunos-
taining was found only in 63% of the control and 70%
of the incompetent GSV specimens and remained at a
relatively low level. Its presence was noted in the vein
media, especially at the border of the intima. The
numbers of p53, p21 and BCl-2 positive cells in the
vein media are presented in Fig. 4.
The levels of anti-p21 and anti-BCL-2 immunostain-
ing in the vein media of the proximal GSV segments
corresponded to the mRNA expression level in both
proximal and distal vein segments. Concerning p53
mRNA and protein expression this relationship was
found only in the distal segment of the veins.
Strong Bax immunoreactivity was present in all
control and varicose specimens concerning all the vein
layers, especially intima (CCC/CCC) and media
(CC/CC). In the varicose vein patients, a lower level
of staining was noticed in the adventitia of the distal
GSVs (control CC vs incompetent GSVC). Despite
the higher BAX mRNA expression, in the distalEur J Vasc Endovasc Surg Vol 28, December 2004incompetent GSV segments the increase o BAX protein
staining was not confirmed.Discussion
According to the ‘weak wall’ theory of varicose veins,
changes of elastin, collagen and SMC amounts can be
responsible for venous tone decrease and vein
dilation, although there are some very controversial
data concerning the number of SMCs in the varicose
vein wall.1,16–18 In the published papers, an increase or
decrease in the amount of SMCs was reported.1,2,19–21
Such differences could be related to the presence of
very inhomogeneous, often hypertrophy or atrophic
vein segments during the disease course.1,18,21,22
At the cellular level, one of the molecular mechan-
isms that could influence on the amount of the SMCs
within the vessel wall is programmed cell death.11–13
In the performed study, an increase of the media
apoptotic index was found in the distal dilated GSV of
the young subjects only. In this group, in comparison
with the control specimens, the decrease of the SMCs
in the media was observed, corresponding to the
positive correlation between p53 mRNA expression
and media apoptotic index. Simultaneously, both p53
mRNA expression level and number of p53—positive
cells within the vein media in this group was higher
than in the control. Such findings were not obtained in
the distal segments of the elderly patients.
P53 is a tumor suppressor gene important for cell
cycle arrest or apoptosis.6–8,23 Various ways of p53
mediated apoptosis are proposed.6,24 One of those
described takes into consideration BCL-2 family
involvement.23–26 In our study, in the young patient
group, the ratio of proapoptotic BAX to antiapoptotic
BCL-2 mRNA expression level differ significantly from
1 in the control to 3.2 in the dilated distal GSVs. Other
factors related to the apoptotic death could also be
taken into consideration such as: p53-mediated and
BAX-independent pathways or an influence of other
BCL-2 family members like BAG, BIM or BCL-X which
were not assessed in the study.6–9,13,25
In the distal incompetent GSV segments, the
described SMC amount decrease was accompanied
by collagen accumulation. One of the characteristic
Fig. 3. (a–d) Expression levels of p53, p21, BCL-2 and BAX
(relative to GAPDH) in control the control [,] and
incompetent [6] GSVs (groups according to the patient
age and harvested vein segments—proximal and distal
GSV). The level of statistical significance: *p!0.05, **p!0.1.
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matrix accumulation. However, the content of cellular
and extracellular compounds is still discussed.16,19,20,27–
29 Some authors confirm collagen accumulation,
whereas according to others the amount of collagen is
reduced.1,22,20,28 Also the elastin amount can be reduced,
unchanged, or increased.1,20,28
Another important pathology is related to the
destruction of the wall architecture resulting in the
injury of local contractile units.1,6,29 Vein wall disten-
sibility is controlled by elastin, collagen and SMCs and
its tone is influenced by circulating factors and
autonomic nerves.1–3,30–32 The reported SMC substi-
tution by the extracellular matrix leads to the venous
tone decrease due to mechanical contractile deficiency
and due to changes in elastic and mechanical proper-
ties.2,16,29,30 This data explains the importance of the
primary vein wall dysfunction, leading to dilation.
According to the literature, in 10–33% of cases varicose
veins of the GSV occur without femoral junction
incompetence and the vein implanted into the arterial
system does not dilate but becomes hypertrophic.1,32–35
These facts support the hypothesis that isolated back
pressure (e.g. due to valve incompetence) is insuffi-
cient for to explain the development of varicose
veins.1,2,16,32
One of the proposed important factors leading to
the elastic network disruption, venous tone decrease
and collagen accumulation is a change of SMC
phenotype from a contractile to a secretory one.17,19,21
This phenotypic change results in enhanced extra-
cellular matrix production has been documented in
atherosclerotic plaques and other vascular con-
ditions.8,9,36,37 According to electron microscopy and
morphological analysis, there are also reports
suggesting a similar pathology in varicose veins.16,17,
19,21 An increase in SMC diameter, the presence of
intracellular vacuoles, disruption of the fibres of the
elastic network contacting hypertrophic secretory
SMCs, and extracellular matrix accumulation were
documented.17,19,21 Additionally, in varicose veins the
presence of some cytokines that could be responsible
for this phenomenon were reported, such as TGF-b1 or
bFGF.21,32 TGF-b1 is a member of the superfamily of
cytokines and it regulates apoptosis, cell proliferation
and differentiation.38–40 The mechanism of TGF-b1
intracellular signaling is related to the SMAD protein
cascade.38 In the further investigations, we showed the
enhanced expression of SMAD 2 and a decrease in
inhibitory SMAD 7 in varicose veins (publication in
progress), which confirms the presence of TGF-b1
related SMC activation in patients with varicose veins.
In the group of older patients, with a longer disease
course and more advanced structural changes, theEur J Vasc Endovasc Surg Vol 28, December 2004
Fig. 4. The numbers (mean, SD) of p53, p21 and BCl-2 positive cells per 1000 cells in control and incompetent GSVs.
(*differences statistically significant p!0.05) (,) control; ( ) incompetent GSVs.
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vein media of distal vein segments was not observed.
No differences concerning p53 mRNA expression level
and number of p53-positive cells in this group could
be found either. On the other hand, in these patients in
the distal vein segment, the percentage of the SMCs
was significantly higher than in the young patient
group (although still much smaller than in the
control). We suggest that p53-related apoptosis,
which in the young population (with a shorter disease
duration) eliminates SMCs from this wall layer, is
downregulated in the further course of the disease.
This results in the SMC preservation, further extra-
cellular matrix deposition and structural changes
increase that could be related to the secretory SMC
accumulation. According to this observation, apopto-
sis seems to play a role in the initial stage of the
pathology but in the advanced stages of the disease a
very low level of apoptotic activity is observed.
Increased sensitivity of human vascular smooth
muscle cells to p53-mediated apoptosis was also
documented in other vascular pathologies such as
atherosclerotic plaques or restenosis after endovascu-
lar treatment.41,42
The apoptotic activity could be related to the
presence of the secretory SMC accumulation within
vein wall as well as explaining elimination of
contractile SMCs. However, in such a situation an
increase of the apoptotic index should also be present
in the elderly patients with more advanced structural
changes, a feature which was not observed in our
study.
Very controversial data have been reported in
previous publications concerning the role of apoptosis
in varicose veins,. By the means of TUNEL method,
Bujan and co-workers found a very high apoptoticEur J Vasc Endovasc Surg Vol 28, December 2004activity within media of harvested varicose veins.11
These data have not been confirmed by others. In the
papers of Ascher, programmed cell death and
expression of the BCL-2 in patients with varicose
veins were investigated and no increase in the
apoptotic cell rate in the intima or media was
found.12 The authors suggested that in varicose veins
downregulation of apoptosis occurred. This effect was
confirmed in their further study where an elevated
level of proapoptotic protein BAX in healthy veins and
a lack of its expression in the adventitia of the varicose
veins was documented.13
In our investigation an increased rate of apoptosis
was noticed only in the media of the distal segment of
young varicose vein patients. These changes were not
observed in the proximal segments. However, in these
vein specimens in comparison with the control veins,
the amount of SMC was reduced in the young
population.
The reduced accumulation of collagen in the vein
wall of the saphenofemoral junction compared to
distal vein segments suggests another mechanism
(probably unrelated to the high back pressure present
in the distal GSV). In our study, in the proximal dilated
GSV segments enhanced p21 and p53 mRNA
expression were found. The number of p21 positive
cells in the media of the proximal incompetent GSVs
was significantly higher than in the controls. In
contrast, in the vein media the number of p53-positive
cells did not differ significantly between the competent
or incompetent proximal GSVs despite a higher p53
mRNA expression.
P21 is a cyclin dependent kinase inhibitor stimulat-
ing cell cycle arrest and its enhanced expression could
confirm some previous findings suggesting the role of
cell cycle regulatory factors (e.g. Retinoblastoma
Apoptosis in Varicose Veins 609protein—Rb) in the pathogenesis of varicose
veins.5–7,43 Beside the precisely described relationship
between p53 and p21 in cell cycle regulation, there are
also data describing the possibility of TGF-b1 related
and p53-dependent or independent induction of
p21.24,40,44,45
There is still discussion as to what comes first—vein
wall injury or valve mechanism destruction—in the
aetiology of varicose veins.1,2,16 We could not find
enhanced apoptosis in the region of the valve annulus.
However, the structural changes also concerned these
vein segments. In the model of the disease taken for
study only proximal (near to the GSV junction) and
distal (calf) segments were dilated. Because there was
no significant dilation of the medial part it can be
supposed that (even if present) valve incompetence
should be accompanied by other wall dysfunction.
The value of the apoptotic index in the present
study was relatively low but the particular method of
this index measurement should be taken into account
(not limited to the selected fields, but related to the
total cell number in the specimens). The values
obtained suggest a very low level of apoptotic cell
death within the vein and varicose vein wall.
SMC disturbances also involved the vein intima.
Thickening of this layer due to extracellular matrix
and atypical (secretory) SMC accumulation in varicose
veins has already been described in the literature.2,3,17,21
Such hypertrophy could be related to a response to the
chronic back pressure and in our study this concerned
especially the dilated distal (calf) GSV (due to intima
thickening, the total collagen and SMC amounts
within the intima increased, but this was not
accompanied by a change of the apoptotic index
within this layer).
In the adventitia of the veins, the apoptotic cells
were mostly a-actin—or CD 68-positive. In the control
group the correlation between BAX mRNA expression
and apoptotic index was observed, but this was not
confirmed in the varicose veins where low immuno-
positivity of pro-apoptotic BAX in this layer was
noticed. According to the literature, apoptosis is an
important inflammation limiting factor-in the case of
inflammatory cell apoptosis inhibition, persistence of
subclinical inflammation may be suspected, which can
play a role in the vein injury.46 Despite the lack of
the localized inflammatory cell infiltrations within the
wall of our samples, the role of inflammation in the
pathogenesis of chronic venous insufficiency should
be always taken into consideration.47
Further, mechanisms leading to the vein wall injury
should also be evaluated, such as the influence of
hormonal factors, endothelial ischaemia and injury, or
proteolytic enzyme activity within the vein wall.32,48The inhibition of matrix metalloproteinases, accumu-
lation of collagen type I and reduction of type III and
IV with improper vein wall response to vasoconstric-
tion factors were evaluated as well.31,47,49 The role of
endothelin B receptors, other cytokines such as VEGF
or increased expression of the endothelial adhesions
molecules ICAM-1 in patients with varicose veins
have also been demonstrated.32,50 Recently new data
confirming the genetic background of the disease have
been published, but the genes involved have not been
identified.4 In some other studies hypoplasia or
atrophy of the vein valves were documented as
described above, but it does not seem to be the only
factor that is responsible for vein dilation.1,2,16,32
Varicose disease is a dynamic process with primary
pathology concerning mostly a dysplastic vein wall
that leads to further dilation.Conclusions
P53-related apoptosis is one of the regulatory mech-
anisms of vein wall homeostasis. During varicose vein
development its activation occurs in the early stages of
the disease. Later in the disease process downregula-
tion of the SMC apoptosis within the vein media leads
to an increase in structural changes.
The reduction of the SMC population corresponds
to an increase of p21 expression in proximal saphenous
vein segments suggesting that the cell cycle disturb-
ances may lead to the ‘weakness’ of the proximal GSV
wall.
Valve injury is not the only factor leading to the
varicose veins—for vein dilation additional factors are
necessary. This may be relevant in clinical practice
when deciding whether or not to strip an undilated
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